收藏切换
Research progress in VEGFR-2 inhibitors
收藏切换
PDF
Peng LIU, Yun-fei ZHOU, Yong ZHANG, Gui-min WANG, Zhao-qiang CHEN, Bo LI, Zhi-jian XU, Wei-liang ZHU*
Acta Pharmaceutica Sinica | 2017, 52(4) : 531 - 540
Less
收藏切换
Acta Pharmaceutica Sinica | 2017, 52(4): 531-540
REVIEWS
Research progress in VEGFR-2 inhibitors
Full
Peng LIU, Yun-fei ZHOU, Yong ZHANG, Gui-min WANG, Zhao-qiang CHEN, Bo LI, Zhi-jian XU, Wei-liang ZHU*
Affiliations
  • ACS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Published: 2017-04-12 doi: 10.16438/j.0513-4870.2016-1103
Outline
收藏切换

Vascular endothelial growth factor receptor (VEGFR-2), a member of the super family of protein tyrosine kinase receptors, plays a vital role in the regulation of tumor metastasis and angiogenesis. Several VEGFR-2 inhibitors have been marketed as antitumor drugs and a range of inhibitors are undergoing clinical or preclinical studies. According to the principle of multi-targeted pharmacolgy, in the field of tumor treatment, nonselective drugs targeting on more than one kinase to inhibit different cell pathways can be more effective than drugs specific for one kinase. Multi-target treatment does not mean abandonment of selectivity, but a precise selectivity for several kinases related to tumor, which is also a big challenge in the development of small molecular antitumor drugs. This paper reviews briefly the advances in research of the VEGFR-2 inhibitors and selectivity strategy in recent years.

VEGFR-2  /  inhibitors  /  tumor  /  selectivity
Peng LIU, Yun-fei ZHOU, Yong ZHANG, Gui-min WANG, Zhao-qiang CHEN, Bo LI, Zhi-jian XU, Wei-liang ZHU. Research progress in VEGFR-2 inhibitors[J]. Acta Pharmaceutica Sinica, 2017 , 52 (4) : 531 -540 . DOI: 10.16438/j.0513-4870.2016-1103
Year 2017 volume 52 Issue 4
PDF
170
59
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2016-1103
  • Receive Date:2016-11-14
  • Online Date:2026-01-14
  • Published:2017-04-12
Article Data
Affiliations
History
  • Received:2016-11-14
  • Revised:2016-12-16
Funding
Affiliations
    ACS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2016-1103
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT